New computer simulation could light the way to safer cannabinoid-based pharmaceuticals
Peer-Reviewed Publication
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 21-Apr-2026 22:16 ET (22-Apr-2026 02:16 GMT/UTC)
An artificial intelligence (AI) model created by integrating clinical, molecular, and histopathological data significantly improved recurrence risk stratification in hormone receptor (HR)-positive, HER2-negative breast cancer, according to results presented at the San Antonio Breast Cancer Symposium (SABCS), held December 9-12, 2025.
Offering screening for neurodivergence to people detained by the police could help ensure access to appropriate support and fairer treatment in the criminal justice system, say Cambridge researchers, after a study suggests that one in two individuals arrested and detained in London may have undiagnosed attention-deficit/hyperactivity disorder (ADHD) and one in 20 may have undiagnosed autism.
The first start-up focused on intelligent humanoid robotics “made in Italy” is being launched at the Italian Institute of Technology (IIT) in Genoa, supported by an investment round of 70 million euros—one of the most significant in Europe in the deep-tech sector. The start-up, called Generative Bionics, stems from the Institute’s research on humanoid robotics and is preparing to establish itself as a key reference point in Europe. The round was led by the Artificial Intelligence Fund of CDP Venture Capital, with the participation of AMD Ventures, Duferco, Eni Next, RoboIT and Tether.